Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients
Hyperhomocysteinemia plays a crucial role in the pathogenesis of many diseases of the central nervous system (CNS). The nervous system is particularly sensitive to high homocysteine (Hcy) level mainly due to its prooxidative and cytotoxic effects. Cladribine, a drug recently registered for the treat...
Main Authors: | Anna Jamroz-Wiśniewska, Jerzy Bełtowski, Grażyna Wójcicka, Halina Bartosik-Psujek, Konrad Rejdak |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2020/1654754 |
Similar Items
-
CSF and serum total-tau and phospho-tau(181P) in MS patients
by: Jaworski Jacek, et al.
Published: (2011-04-01) -
Hydrogen Sulfide and Endothelium-Dependent Vasorelaxation
by: Jerzy Bełtowski, et al.
Published: (2014-12-01) -
Hydrogen Sulfide in the Adipose Tissue—Physiology, Pathology and a Target for Pharmacotherapy
by: Jerzy Bełtowski, et al.
Published: (2016-12-01) -
Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine
by: Teri L. Schreiner, et al.
Published: (2012-04-01) -
Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine
by: Teri L. Schreiner, et al.
Published: (2012-01-01)